Recent Advances in Aptamers Targeting Immune System

被引:13
|
作者
Hu, Piao-Ping [1 ,2 ]
机构
[1] Nanchang Univ, Affiliated Hosp 1, Dept Gastroenterol, Nanchang 330006, Jiangxi, Peoples R China
[2] Nanchang Univ, Affiliated Hosp 1, Dept Blood Transfus, Nanchang 330006, Jiangxi, Peoples R China
关键词
aptamer; immune system; inflammation; therapy; RNA APTAMER; HIGH-AFFINITY; DNA APTAMERS; INTERLEUKIN-6; RECEPTOR; INNATE IMMUNITY; TNF-ALPHA; CELLS; LIGANDS; MOLECULES; SELECTION;
D O I
10.1007/s10753-016-0437-9
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The immune system plays important role in protecting the organism by recognizing non-self molecules from pathogen such as bacteria, parasitic worms, and viruses. When the balance of the host defense system is disturbed, immunodeficiency, autoimmunity, and inflammation occur. Nucleic acid aptamers are short single-stranded DNA (ssDNA) or RNA ligands that interact with complementary molecules with high specificity and affinity. Aptamers that target the molecules involved in immune system to modulate their function have great potential to be explored as new diagnostic and therapeutic agents for immune disorders. This review summarizes recent advances in the development of aptamers targeting immune system. The selection of aptamers with superior chemical and biological characteristics will facilitate their application in the diagnosis and treatment of immune disorders.
引用
收藏
页码:295 / 302
页数:8
相关论文
共 50 条
  • [41] Recent Advances in Chemical Biology of Mitochondria Targeting
    Wang, Haiwei
    Fang, Bin
    Peng, Bo
    Wang, Limin
    Xue, Yufei
    Bai, Hua
    Lu, Shenci
    Voelcker, Nicolas H.
    Li, Lin
    Fu, Li
    Huang, Wei
    FRONTIERS IN CHEMISTRY, 2021, 9
  • [42] Vascular targeting: Recent advances and therapeutic perspectives
    Hajitou, A
    Pasqualini, R
    Arap, W
    TRENDS IN CARDIOVASCULAR MEDICINE, 2006, 16 (03) : 80 - 88
  • [43] Recent advances targeting chemokines for breast cancer
    Zhang, Yanan
    Tang, Xiufeng
    Wang, Ying
    Shi, Fengcui
    Gao, Xing
    Guo, Yingxin
    Liu, Qian
    Ma, Wenjian
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2025, 146
  • [44] Targeting neovascularization in ischemic retinopathy: recent advances
    Al-Shabrawey, Mohamed
    Elsherbiny, Mohamed
    Nussbaum, Julian
    Othman, Amira
    Megyerdi, Sylvia
    Tawfik, Amany
    EXPERT REVIEW OF OPHTHALMOLOGY, 2013, 8 (03) : 267 - 286
  • [45] Development of Cell-Specific Aptamers: Recent Advances and Insight into the Selection Procedures
    Rahimizadeh, Kamal
    AlShamaileh, Hadi
    Fratini, Milena
    Chakravarthy, Madhuri
    Stephen, Michelle
    Shigdar, Sarah
    Veedu, Rakesh N.
    MOLECULES, 2017, 22 (12):
  • [46] RECENT ADVANCES IN FORENSIC TOXICOLOGY: NUCLEIC ACID APTAMERS FOR ILLICIT DRUG DETECTION
    Zeng, L.
    Pawlowska, N.
    Liu, Z. C.
    Han, X.
    Zhou, H.
    Hao, H. X.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2015, 117 : 21 - 22
  • [47] Targeting Antitumor Immune Response for Enhancing the Efficacy of Photodynamic Therapy of Cancer: Recent Advances and Future Perspectives
    Yang, Yamin
    Hu, Yue
    Wang, Hongjun
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2016, 2016
  • [48] Recent Advances in Liposomal Drug Delivery System of Quercetin for Cancer Targeting: A Mechanistic Approach
    Das, Sabya S.
    Hussain, Afzal
    Verma, Priya R. Prasad
    Imam, Syed S.
    Altamimi, Mohammad A.
    Alshehri, Sultan
    Singh, Sandeep Kumar
    CURRENT DRUG DELIVERY, 2020, 17 (10) : 845 - 860
  • [49] Recent advances of immune checkpoint in breast cancer
    Zhong, Lili
    Zhao, Yinlong
    Zhang, Kun
    Li, Xin
    Cui, Ranji
    Yang, Wei
    BIOMEDICAL RESEARCH-INDIA, 2017, 28 (16): : 7268 - 7273
  • [50] Recent advances in the mechanisms and treatment of immune thrombocytopenia
    Provan, Drew
    Semple, John W.
    EBIOMEDICINE, 2022, 76